selegiline has been researched along with Chemical Dependence in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 10 (76.92) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charkhpour, M; Ghaderi, M; Habibi-asl, B; Hassanzadeh, K; Parvizpour, A; Shakhsi, M | 1 |
| Gaál, J; Justinova, Z; Molnár, SV; Panlilio, LV; Redhi, GH; Schindler, CW; Yasar, S | 1 |
| Williams, A | 1 |
| Bigelow, GE; Garner, JE; Ginn, DH; Haberny, KA; Setoda, D; Walsh, SL; Wilkins, JN | 1 |
| Bergman, J; Goldberg, SR; Yasar, S; Youdim, MB | 1 |
| Goldstein, B; Schneider, LS; Tariot, PN | 1 |
| Nickel, B; Schulze, G; Szelenyi, I | 1 |
| Goldberg, SR; Negus, SS; Winger, GD; Yasar, S | 1 |
| Baker, LS | 1 |
| Demuth, M; Götz, ME; Koutsilieri, E; Riederer, P; Sauer, U; Sopper, S; ter Meulen, V | 1 |
| Keppel Hesselink, JM | 1 |
| Fukushima, S; Hasegawa, M; Kimura, K; Maseda, C; Matsubara, K; Uezono, T | 1 |
| Knoll, B; Knoll, J; Timár, J; Yasar, S | 1 |
2 review(s) available for selegiline and Chemical Dependence
| Article | Year |
|---|---|
Introduction: examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline).
Topics: Animals; Humans; Selegiline; Substance-Related Disorders | 1994 |
Therapy with l-deprenyl (selegiline) and relation to abuse liability.
Topics: Alzheimer Disease; Depressive Disorder; Drug Synergism; Humans; Parkinson Disease; Selegiline; Substance-Related Disorders | 1994 |
1 trial(s) available for selegiline and Chemical Dependence
| Article | Year |
|---|---|
Absence of acute cocaine interactions with the MAO-B inhibitor selegiline.
Topics: Administration, Oral; Adult; Arousal; Blood Pressure; Cocaine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Euphoria; Heart Rate; Humans; Infusions, Intravenous; Male; Monoamine Oxidase Inhibitors; Reflex, Pupillary; Selegiline; Substance Withdrawal Syndrome; Substance-Related Disorders | 1995 |
10 other study(ies) available for selegiline and Chemical Dependence
| Article | Year |
|---|---|
Repeated central administration of selegiline attenuated morphine physical dependence in rat.
Topics: Animals; Infusions, Intraventricular; Male; Morphine; Morphine Dependence; Naloxone; Rats; Rats, Sprague-Dawley; Rats, Wistar; Selegiline; Substance Withdrawal Syndrome; Substance-Related Disorders | 2013 |
A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.
Topics: Animals; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Dose-Response Relationship, Drug; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Reinforcement Schedule; Saimiri; Selegiline; Self Administration; Stereoisomerism; Substance-Related Disorders | 2006 |
MPTP parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Animals; Humans; Male; Mice; Parkinson Disease, Secondary; Pyridines; Saimiri; Selegiline; Substance-Related Disorders | 1984 |
Evaluation of physical dependence liability of l-deprenyl (selegiline) in animals.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Electroencephalography; Female; Male; Rats; Rats, Sprague-Dawley; Selegiline; Stereoisomerism; Substance-Related Disorders; Time Factors | 1994 |
Intravenous self-administration studies with l-deprenyl (selegiline) in monkeys.
Topics: Animals; Injections, Intravenous; Macaca mulatta; Selegiline; Self Administration; Substance-Related Disorders | 1994 |
"Smart drugs": a caution to everybody.
Topics: Advertising; Humans; Intelligence; Male; Mental Processes; Nonprescription Drugs; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Selegiline; Self Medication; Substance-Related Disorders | 1996 |
Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro.
Topics: AIDS Dementia Complex; Carrier Proteins; Cell Survival; Cells, Cultured; Cocaine; Disease Progression; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Glutathione; HIV-1; Humans; Macrophages; Membrane Glycoproteins; Membrane Transport Proteins; Morphine; Narcotics; Nerve Tissue Proteins; Oxidative Stress; Selegiline; Substance-Related Disorders; Tumor Cells, Cultured; Up-Regulation | 1997 |
['Smart drugs' enticements on the Internet].
Topics: Advertising; Computer Communication Networks; Human Growth Hormone; Humans; Illicit Drugs; Nonprescription Drugs; Nootropic Agents; Phenytoin; Selegiline; Self Medication; Substance-Related Disorders | 1998 |
Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy.
Topics: Adult; Amphetamine; Amphetamines; Biomarkers; Chromatography, Gas; Diagnosis, Differential; Female; Humans; Male; Methamphetamine; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Stereoisomerism; Substance Abuse Detection; Substance-Related Disorders | 1999 |
Comparison of the dependence capacity of amphetamine, MK-306 and (-)deprenyl.
Topics: Amphetamine; Animals; Cefoxitin; Learning; Phenethylamines; Rats; Selegiline; Substance-Related Disorders | 1990 |